JPMorgan Chase & Co. Cuts Badger Meter (NYSE:BMI) Price Target to $170.00
JPMorgan Chase & Co. cut its Badger Meter (NYSE:BMI) price target to $170 from $172 and kept an “overweight” rating, implying about 37.5% upside from the prior close, according to JPMorgan. The stock traded at $123.62 after a 2.4% drop. BMI reported Q2 EPS of $1.02 and revenue of $220.3 million.
How this was made
The 30-second read
Why it matters
For traders, the actionable element is the updated JPMorgan price target ($170 vs $172) with an unchanged “overweight” rating, which can influence short-term sentiment but is unlikely to force a major repricing absent a rating change or new fundamental datapoint.
Market read
This is primarily an analyst-target update with modest magnitude, so it is more sentiment-relevant than fundamentals-relevant.
What to watch
The body also references recent earnings (EPS slightly above consensus but revenue down YoY) and mentions legal overhang reminders, which could matter more than the small target adjustment for near-term risk pricing.
Background
The article summarizes a JPMorgan research update to Badger Meter’s valuation, alongside other analysts’ recent rating/target changes and a recap of the company’s latest earnings.
Ticker impact
JPMorgan cut Badger Meter’s price target to $170 from $172 while keeping an “overweight” rating, signaling a modest valuation reset.
Likely modest, short-lived pressure on BMI as traders reprice the updated target, with upside still supported by the unchanged “overweight” stance.
The article’s newest concrete item is the JPMorgan target reduction; it is only a $2 change and the rating remains overweight, so the incremental signal is moderate rather than a thesis break.
Market effects
Limited read-across to the water-meter/flow-measurement equipment space because the update is a single-name target trim, not a sector-wide catalyst.
No clear regional spillover indicated; the news is analyst-driven for a US-listed industrial.
Minimal global relevance; the article does not cite international regulatory or demand shocks.
Counterpoint
The target cut may be more about fine-tuning than deteriorating fundamentals, especially since JPMorgan kept “overweight” and the stock recently traded down on the day.
Key entities
- equityBadger Meter
Scientific and technical instruments company (NYSE: BMI) whose price target was trimmed by JPMorgan.
- brokerage/analystJPMorgan Chase & Co.
Issued the research report reducing the target price from $172 to $170 while maintaining “overweight”.
